Samsung Biologics Market Cap

Samsung Biologics has a market cap or net worth of 76.7 trillion as of March 11, 2026. Its market cap has increased by 5.24% in one year.

Market Cap

76.70T

Enterprise Value

76.15T

Revenue

4.56T

Ranking

n/a

PE Ratio

68.78

Stock Price

1,629,000.00

Market Cap Chart

Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 76.70T, an increase of 705.06%. That is a compound annual growth rate of 25.03%.

Market Cap History

Date	Market Cap	% Change
Mar 11, 2026	76.70T	-2.24%
Dec 30, 2025	78.46T	16.17%
Dec 30, 2024	67.54T	24.87%
Dec 28, 2023	54.09T	-7.43%
Dec 29, 2022	58.43T	-2.20%
Dec 30, 2021	59.75T	9.32%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Nov 10, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Celltrion	45.09T
ALTEOGEN	20.08T
SK Biopharmaceuticals	7.82T
Peptron	6.74T
HLB Co., Ltd.	6.70T
LigaChem Biosciences	6.57T
Voronoi	5.76T
OliX Pharmaceuticals	3.76T

Market Cap Rankings